Journal of Clinical Epidemiology
Volume 63, Issue 10 , Pages 1132-1144, October 2010

The quality of eight health status measures were compared for chronic opioid dependence

  • Bohdan Nosyk

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
  • ,
  • Huiyung Sun

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
  • ,
  • Daphne P. Guh

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
  • ,
  • Eugenia Oviedo-Joekes

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
  • ,
  • David C. Marsh

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
    • School of Population and Public Health, University of British Columbia, British Columbia, Canada
    • Vancouver Coastal Health Authority, British Columbia, Canada
    • Centre for Addictions Research BC, British Columbia, Canada
  • ,
  • Suzanne Brissette

      Affiliations

    • Centre de recherche du l'Université de Montreal, Quebec, Canada
  • ,
  • Martin T. Schechter

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
    • School of Population and Public Health, University of British Columbia, British Columbia, Canada
  • ,
  • Aslam H. Anis

      Affiliations

    • Centre for Health Evaluation and Outcome Sciences, British Columbia, Canada
    • School of Population and Public Health, University of British Columbia, British Columbia, Canada
    • Corresponding Author InformationCorresponding author. Centre for Health Evaluation & Outcome Sciences, St. Paul's Hospital, 620B-1081 Burrard Street, Vancouver, BC V6Z 1Y6, Canada. Tel.: +604-806-8692; fax: +604-806-8778.

published online 18 March 2010.

Abstract 

Objective

To provide a comparative analysis of the psychometric properties of eight measures of health status among chronic opioid-dependent patients.

Study Design and Setting

Longitudinal data were analyzed for 251 patients enrolled in the North American Opiate Medication Initiative randomized controlled trial, conducted in Vancouver, British Columbia and Montreal, Quebec, Canada. Content validity, evidence of floor and ceiling effects, internal consistency, construct validity, and responsiveness were assessed for the Addiction Severity Index (ASI) medical and psychiatric (ASImed and ASIpsych) composite scores, the Maudesley Addiction Profile (MAP) physical and mental health scores (MAP-physical health score [MAP-PHS], MAP-mental health score [MAP-MHS]), the World Health Organization Disability Assessment Schedule-II, the EuroQol Group's EQ-5D index score and visual analog scale, EuroQol visual analog scale (EQ-VAS), and the Short Form SF-6D index score.

Results

ASImed was best able to discriminate among patients with and without chronic conditions. The MAP-PHS and MAP-MHS were not unidimensional. ASImed and ASIpsych had prominent ceiling effects. ASImed, MAP-MHS, MAP–PHS, EQ-VAS, and EQ-5D were all responsive to decreases in illicit drug use.

Conclusion

None of the instruments performed uniformly as “best” or “worst.” The EQ-5D appeared to be the preferable generic, indirect utility measure. Our results provide an evidence base to inform selection and further development of health status measures in opioid-dependent populations.

Keywords: Opioid dependence, Addiction Severity Index, EQ-5D, SF-6D, Responsiveness, Maudsley Addiction Profile, WHODAS-12

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Source of support: The North American Opiate Medication Initiative was supported by a Canadian Institutes of Health Research operating grant.

PII: S0895-4356(09)00388-6

doi:10.1016/j.jclinepi.2009.12.003

Journal of Clinical Epidemiology
Volume 63, Issue 10 , Pages 1132-1144, October 2010